The health effects of artificial sweeteners: Towards personalized quantification and prediction through gut microbiome  

作　　者：Yongjun Wei Boyang Ji 

机构地区：[1]School of Pharmaceutical Sciences,Laboratory of Synthetic Biology,Key Laboratory of Advanced Drug Preparation Technologies,Ministry of Education,Zhengzhou University,Zhengzhou 450051,China [2]BioInnovation Institute,Ole Maaløes Vej 3,DK2200 Copenhagen N,Denmark

出　　处：《Eco-Environment & Health》2023年第3期89-91,共3页生态环境与健康（英文）

基　　金：funded the National Natural Science Foundation of China(No.32111530179).

摘　　要：Artificial sweeteners(AS)have been widely applied in the food industry as sugar substitutes with reduced calorie content but high sweetening power[1].The consumption of sugar-sweetened beverages is associated with the incidence of obesity and type 2 diabetes[2,3].Non-caloric AS(NCAS)have been recommended for weight management and as a treatment strategy for type 2 diabetes[4].While AS are generally considered safe with acceptable daily intake by regulatory agencies(e.g.,European Food Safety Authority,US Food and Drug Administration),mounting epidemiological evidence shows that the consumption of AS is associated with the risk of cardiometabolic disease[2,3,5].

关 键 词：INTAKE SUGAR artificial 

分 类 号：R589.2[医药卫生—内分泌]